| human | Q5 |
| P2798 | Loop ID | 734848 |
| P496 | ORCID iD | 0000-0002-8535-630X |
| P1053 | ResearcherID | C-2270-2009 |
| P1153 | Scopus author ID | 26424031500 |
| P108 | employer | University of Sheffield | Q823917 |
| Sheffield Teaching Hospitals NHS Foundation Trust | Q7492756 | ||
| P106 | occupation | researcher | Q1650915 |
| Q38803967 | A 17-year experience in perioperative anaphylaxis 1998-2015: harmonizing optimal detection of mast cell mediator release |
| Q112241363 | Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper |
| Q37438932 | BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease |
| Q39205579 | British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders. |
| Q40337213 | Chlorhexidine allergy in four specialist allergy centres in the United Kingdom, 2009-13: clinical features and diagnostic tests. |
| Q58422030 | Clinical and laboratory features of seventy-eight UK patients with Good’s syndrome (thymoma and hypogammaglobulinaemia) |
| Q37664364 | Cryoglobulin evaluation: best practice? |
| Q39491956 | Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma. |
| Q38871705 | Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper |
| Q47440957 | ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonise assay performance across centres. |
| Q78065854 | Localized hypertrophy of hand in syringomyelia |
| Q92998212 | Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses |
| Q52686808 | Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. |
| Q38401392 | Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK. |
| Q53171088 | NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders. |
| Q37963483 | Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update |
| Q52686806 | Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency. |
| Q101134275 | Production of Trimeric SARS-CoV-2 Spike Protein by CHO Cells for Serological COVID-19 Testing |
| Q24647314 | Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen |
| Q50892304 | Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time. |
| Q50527118 | Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay. |
| Q48222646 | Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. |
| Q38954495 | Susceptibility to mycobacterial infection in a young man with a hypoglossal nerve palsy: the hunt for an immunological defect. |
| Q57159550 | The European Society for Immunodeficiencies (ESID) registry 2014 |
| Q44125989 | The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012. |
| Q88854780 | Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care |
Search more.